GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
25,050
+50 (0.20%)
Apr 29, 2026, 2:10 PM KST
GemVax&KAEL Revenue
In the year 2025, GemVax&KAEL had annual revenue of 81.53B KRW with 30.05% growth. GemVax&KAEL had revenue of 26.16B in the quarter ending December 31, 2025, with 43.18% growth.
Revenue
81.53B
Revenue Growth
+30.05%
P/S Ratio
13.48
Revenue / Employee
447.97M
Employees
182
Market Cap
1,098.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.53B | 18.84B | 30.05% |
| Dec 31, 2024 | 62.69B | -9.52B | -13.18% |
| Dec 31, 2023 | 72.21B | -3.60B | -4.74% |
| Dec 31, 2022 | 75.80B | 15.43B | 25.56% |
| Dec 31, 2021 | 60.37B | -5.29B | -8.06% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MNC Solution Co.,Ltd | 266.42B |
| SFA Engineering | 1,630.95B |
| Fine Semitech | 280.26B |
| Creative & Innovative System | 407.18B |
| Neuromeka | 18.95B |
| Hyulim ROBOT | 168.30B |
| Robostar | 75.74B |
| Hy-Lok | 214.57B |